LASN01

· Lassen Therapeutics 1 PTY LTD

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LASN01, covering 2024-12-30 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease [Phase 2]